title: [Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
authors.forename: J
authors.initials: J
authors.lastname: Baraia-Etxaburu
authors.forename: P
authors.initials: P
authors.lastname: Malero
authors.forename: M J
authors.initials: MJ
authors.lastname: Unzaga
authors.forename: R
authors.initials: R
authors.lastname: Teira
authors.forename: J
authors.initials: J
authors.lastname: Muñoz
authors.forename: R
authors.initials: R
authors.lastname: Cisterna
authors.forename: J M
authors.initials: JM
authors.lastname: Santamaría
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000193:Actinomycetales Infections / Q000188:drug therapy*; D000328:Adult; D002939:Ciprofloxacin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D016929:Rhodococcus equi / Q000187:drug effects / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D005839:Gentamicins; D002939:Ciprofloxacin; D004917:Erythromycin; D014640:Vancomycin; D017291:Clarithromycin; D012293:Rifampin